+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

Leigh Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Leigh Syndrome Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 477 Pages
  • Global
From
From
Mucopolysaccharidosis Treatment Market Report 2025 - Product Thumbnail Image

Mucopolysaccharidosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Lysosomal Disease Treatment Market Report 2025 - Product Thumbnail Image

Lysosomal Disease Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
From
Niemann Pick C Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Niemann Pick C Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Charcot Marie Tooth Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Charcot Marie Tooth Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
RNA Targeting Small Molecule Drug Discovery Market Report 2025 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
State of the Biopharmaceutical Industry 2023 - Product Thumbnail Image

State of the Biopharmaceutical Industry 2023

  • Report
  • December 2022
  • 110 Pages
  • Global
From
Loading Indicator